Announcement of Jianfeng Group Lin2017 -008 on Providing Guarantee to Holding Subsidists
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Pro 2017-008
Bond Abbreviation: 13 Peak 01 Bond Code: 122227
Bond Abbreviation: 13 Peak 02 Bond Code: 122344
Announcement of Zhejiang Jianfeng Group Co., Ltd.
Providing Guarantees to Holding Subsidiaries
The board of directors and all directors of the company guarantee that the content of this announcement does not contain any False records, misleading statements or major omissions, and bear individual and joint responsibility for the authenticity, accuracy and completeness of its contents .
Important Content Tips
● Names of Guarantees: Zhejiang Jianfeng Pharmaceutical Co., Ltd., Daye Jianfeng Cement Co., Ltd., Zhejiang Jianfeng International Trade Co., Ltd.
● Proposed guarantee amount: set guarantee amount 4.3 .9 billion yuan.
● Is there any counter-guarantee in this guarantee: No
● Cumulative number of overdue external guarantees: No
Overview of 1. guarantees
2017 On April 15, 39, Zhejiang Jianfeng Group Co., Ltd. held the 11th meeting of the 9th Board of Directors, and all eight directors of the company attended the meeting in person; comply with the relevant provisions of the "Company Law" and the "Articles of Association" of the company, and the resolutions made are legal and valid. The meeting was presided over by Chairman Jiang Xiaomeng. After deliberation and voting, the "Proposal on Providing Guarantees for Holding Subsidiaries" was reviewed and passed with 8 votes in favor, 0 votes against, and 0 abstentions.
This motion needs to be submitted to the general meeting of shareholders for consideration.Basic Information of 2. Guarantees
1
, Zhejiang Jianfeng Pharmaceutical Co., Ltd., with a registered capital of 19853 yuan, of which: the company accounts for 99.16 percent, and its registered address is the second floor of X02 Office Quality Inspection Building, No. 58 Gaofan Section, Baitang Downline, Wucheng District, Jinhua City, Zhejiang Province. Its main business is drug research and development and production (operated with valid licenses); import raw materials for production and scientific research; import machinery and equipment, instruments and spare parts. (For projects subject to approval according to law, business activities can only be carried out after approval by relevant departments).
2, daye peak cement co., ltd. has a registered capital of 2.5 .1 billion yuan, of which the company accounts for 6% and the company's holding subsidiary Zhejiang peak cement co., ltd. (the company holds 95.25) accounts for 70%. registered address: daye city hubei province security town; main business: cement, cement clinker, cement mechanical and electrical equipment manufacturing and sales; building materials products such as sales.
3, Zhejiang Jianfeng International Trade Co., Ltd., with a registered capital of 3000 yuan, of which: 93.33 of our company and 6.67 of Jianfeng Pharmaceutical Co., Ltd., registered address: 88 changchun West Road, Jindong Economic Development Zone, Zhejiang Province, mainly engaged in self-management and agency of import and export of various commodities and technologies, engaged in processing of imported materials and "three to one supplement" business; To carry out countertrade and re-export trade, warehousing of bonded and general goods (except dangerous goods), pharmaceutical intermediates, pharmaceutical equipment, etc.
Audited keyfinancial data of the above subsidiaries 2016 (in: ten thousand yuan)
| company name |
total assets |
total liabilities |
total bank loans |
total current liabilities |
net assets |
total operating income |
net profit attributable to parent company owner |
| daye peak cement co., ltd. |
52910.68 |
13875.37 |
13803.94 |
39035.31 |
48836.56 |
5273.45 |
|
| Zhejiang Jianfeng Pharmaceutical Co., Ltd. |
107327.91 |
64705.62 |
3400 |
58149.59 |
42622.29 |
122399.97 |
4528.59 |
| Zhejiang Jianfeng International Trading Co., Ltd. |
6537.97 |
5285.42 |
0 |
5172.92 |
1252.55 |
15089.31 |
169.39 |
1
, to Holding Subsidiary provide guarantees for loans from financial institutions, set the following limits:
| Guaranteed Unit |
Set Guarantee Limit (RMB 10,000) |
| Daye Jianfeng Cement Co., Ltd. |
5000 |
| Zhejiang Jianfeng Pharmaceutical Co., Ltd. |
30000 |
| Zhejiang Jianfeng International Trade Co., Ltd. |
8000 |
| Total |
43000 |
, agreed to be Zhejiang Jianfeng International Trade Co., Ltd. Letter of Guarantee from the Company, provide corresponding guarantee for the goods stored in the company by the customers of Zhejiang Jianfeng International Trade Co., Ltd.
The guarantee within the above amount is authorized to be executed by the chairman of the board of directors.4. the opinion of the board of directors
The above guaranteed companies are all controlling subsidiaries of the company. The company can effectively control the guarantee risks, and the board of directors agrees to the above guarantees.
# The three independent directors of the 296 company issued independent opinions on the matter and believed that the formation of the resolution complied with the "Company Law", the company's "Articles of Association" and other relevant provisions, and did not harm the interests of small and medium shareholders.
5. Cumulative Number of External Guarantees and Number of Overdue Guarantees
As of the disclosure date of this announcement, the total amount of external guarantees approved by the company and its controlling subsidiaries is 12.5
.3 billion yuan, accounting for 52.4 of the total owner's equity attributable to the parent company by the audited consolidated caliber at the end of 2016. Among them, the total amount of approved guarantee for the controlling subsidiary is 650 million yuan, accounting for 27.25 of the total owner's equity attributable to the parent company's audited consolidated caliber at the end of 2016.As of the disclosure date of this announcement, the actual balance of external guarantees of the company and its controlling subsidiaries (excluding subsidiaries) was 5.77
.6 billion yuan, accounting for 24.17 of the total owner's equity attributable to the parent company by the audited merger at the end of 2016. The actual balance of the company's guarantee to the controlling subsidiary is 25 million yuan, accounting for 1.05 of the Company's total audited consolidated equity attributable to owners of the parent company at the end of 2016.As of the disclosure date of this announcement, the company has no overdue guarantee.
6. Reference Document Catalogue
Resolution of the 11th
Meeting of the 9th Board of Directors of the Company;
hereby announce
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors
April 18, 2017
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page